— Published date: 2/10/2026
Value Proposition: Novel non-invasive multielectrode transcutaneous spinal cord stimulation (tSCS) technique capable of selectively activating specific joints.
Technology Description
Researchers at Washington University in St. Louis have developed a new non-invasive s…
— Published date: 1/14/2026
Value Proposition: Entry receptors that bind directly to TBEV, promoting virus attachment to treat TBEV and other viruses.
Technology Description
Researchers at Washington University in St. Louis have developed LRP8 soluble decoy receptors (minimal domains-Fc fusion …
— Published date: 1/14/2026
Value Proposition: Soluble engineered decoy receptor protein that on its own can be used to treat multiple alphavirus types.
Technology Description
Researchers at Washington University in St. Louis have developed a composition of matter that consists of a mutagenized…
— Published date: 1/14/2026
Value Proposition: Decoy receptor therapeutic that can treat multiple VEEV subtypes by blocking VEEV entry and infection.
Technology Description
Researchers at Washington University in St. Louis have developed a decoy Ldlrad3-D1-Fc protein for prevention of treatment o…
— Published date: 1/14/2026
Value Proposition: Novel target for therapeutic treatment of obesity and related metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a therapeutic targeting MXRA8 to treat obesity and associated metabolic disea…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
